- Home
- ORKA vs ACIC Comparison
ORKA vs ACIC Comparison
Compare ORKA & ACIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- ACIC
- Stock Information
- Founded
- ORKA 2004
- ACIC 1999
- Country
- ORKA United States
- ACIC United States
- Employees
- ORKA N/A
- ACIC N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ACIC Property-Casualty Insurers
- Sector
- ORKA Health Care
- ACIC Finance
- Exchange
- ORKA Nasdaq
- ACIC Nasdaq
- Market Cap
- ORKA 580.3M
- ACIC 546.2M
- IPO Year
- ORKA N/A
- ACIC N/A
- Fundamental
- Price
- ORKA $20.43
- ACIC $12.11
- Analyst Decision
- ORKA Strong Buy
- ACIC Buy
- Analyst Count
- ORKA 7
- ACIC 1
- Target Price
- ORKA $43.00
- ACIC $16.00
- AVG Volume (30 Days)
- ORKA 520.4K
- ACIC 156.9K
- Earning Date
- ORKA 11-12-2025
- ACIC 11-05-2025
- Dividend Yield
- ORKA N/A
- ACIC 4.13%
- EPS Growth
- ORKA N/A
- ACIC 14.01
- EPS
- ORKA N/A
- ACIC 1.63
- Revenue
- ORKA N/A
- ACIC $320,072,000.00
- Revenue This Year
- ORKA N/A
- ACIC $4.91
- Revenue Next Year
- ORKA N/A
- ACIC $4.16
- P/E Ratio
- ORKA N/A
- ACIC $7.42
- Revenue Growth
- ORKA N/A
- ACIC 33.90
- 52 Week Low
- ORKA $5.49
- ACIC $8.82
- 52 Week High
- ORKA $31.13
- ACIC $15.08
- Technical
- Relative Strength Index (RSI)
- ORKA 68.72
- ACIC 65.32
- Support Level
- ORKA $18.19
- ACIC $11.04
- Resistance Level
- ORKA $21.18
- ACIC $11.45
- Average True Range (ATR)
- ORKA 1.42
- ACIC 0.29
- MACD
- ORKA 0.41
- ACIC 0.06
- Stochastic Oscillator
- ORKA 89.03
- ACIC 96.46
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary.